Vandana Singh
·
October 15, 2025
Benzinga
Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical devices.
read more
October 19, 2025
September 5, 2025
August 29, 2025
Financial Times
August 22, 2025
September 4, 2025